Skip to main content
ASBP logo

ASBP · Aspire Biopharma Holdings, Inc.

Track ASBP — free
$8.06 +0.09 (+1.13%)
Market Cap
$11.18M
Shares
1.40M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Donald G. Fell Resigned 2026-02-12
Surendra Ajjarapu Resigned 2026-01-13
Barbara Sher Resigned 2025-07-30
Howard Doss Appointed 2025-07-30
Gary Stein Resigned 2025-07-30
Kraig Higginson Appointed 2025-07-30
Michael Howe Resigned 2025-07-30
Michael Howe Appointed 2025-06-10
Kraig Higginson Resigned 2025-06-10
Surendra Ajjarapu Appointed 2025-02-21
Donald G. Fell Appointed 2025-02-21
Edward J. Kimball Appointed 2025-02-21
Barbara Sher Appointed 2025-02-21
Gary Stein Appointed 2025-02-21
Michael Howe Appointed 2025-02-21
Ernest J. Scheidmann Appointed 2025-02-21
Kraig T. Higginson Appointed 2025-02-21
Howard Doss Appointed 2023-08-23
Surendra Ajjarapu Appointed 2023-08-23
Surendra Ajjarapu Appointed 2023-08-23
Mayur Doshi Appointed 2023-08-23
Avinash Wadhwani Appointed 2023-08-23
Gabriel Schillinger Resigned 2023-08-23
Donald G. Fell Appointed 2023-08-23
Michael L. Peterson Appointed 2023-08-23
Key facts CIK 1847345 CUSIP 738920305 13F (30d) 39 filings 38 filers Visit website